Walmart and Humana have explored a wide range of options including a merger, though an outright combination isn't likely at this point, according to one source.
Buying Allergan, which is in Dublin, could let Pfizer relocate outside the U.S. for tax purposes, a transaction known as an inversion--and of course, Allergan has Botox and the Alzheimers drug Namenda.
The share buyback will occur over a multi-year period, the Woonsocket, Rhode Island-based company said in a statement today before a briefing for analysts and investors.
DebugScreen: mobile
{
"author": {
"name": "Ed Hammond",
"webUrl": "/author/profile/ed-hammond/",
"description": "",
"imageLarge": "https://secure.gravatar.com/avatar/f16d6fc2845f417ea0e93a3f2b6cd37d?s=136&d=mm&r=g",
"estimate": 11,
"social": [],
"articles": [
{
"uri": "/2019/03/28/centene-to-buy-managed-care-provider-wellcare/",
"title": "Centene to buy managed-care provider WellCare",
"byline": "Ed Hammond and John Tozzi",
"kicker": "News",
"prettyDate": "March 28, 2019",
"timeToRead": "5 minute",
"image": {
"uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2018/06/pbm-auditing-compliance-pharmacy-shtstk.jpg",
"width": "620",
"height": "422"
},
"authors": [
{
"webUrl": "/author/profile/ed-hammond/",
"name": "Ed Hammond"
},
{
"webUrl": "/author/profile/john-tozzi/",
"name": "John Tozzi"
}
],
"kickerNode": [
{
"uri": "/news/",
"sectionName": "News"
}
],
"summary": "The acquisition expands in the market for government insurance plans just as politicians gear up for another health-policy clash.",
"body": null
},
{
"uri": "/2019/03/05/aon-is-said-to-weigh-bid-for-23b-rival-willis-towers-watson/",
"title": "Aon is said to weigh bid for $23B rival Willis Towers Watson",
"byline": "Ed Hammond, Matthew Monks and Katherine Chiglinsky",
"kicker": "News",
"prettyDate": "March 05, 2019",
"timeToRead": "4 minute",
"image": {
"uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2019/03/acquisition-umbrella-people-company-acquire-deal.jpg",
"width": "616",
"height": "372"
},
"authors": [
{
"webUrl": "/author/profile/ed-hammond-matthew-monks/",
"name": "Ed Hammond, Matthew Monks"
},
{
"webUrl": "/author/profile/katherine-chiglinsky/",
"name": "Katherine Chiglinsky"
}
],
"kickerNode": [
{
"uri": "/news/",
"sectionName": "News"
}
],
"summary": "Buying Willis Towers might enable Aon to overtake Marsh & McLennan Cos. as the world's largest brokerage by revenue.",
"body": null
},
{
"uri": "/2018/11/12/athenahealth-sold-for-5-7-billion/",
"title": "Athenahealth sold for $5.7 billion",
"byline": "Ed Hammond and Scott Deveau",
"kicker": "News",
"prettyDate": "November 12, 2018",
"timeToRead": "2 minute",
"image": {
"uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2018/02/Handshake.jpg",
"width": "600",
"height": "400"
},
"authors": [
{
"webUrl": "/author/profile/ed-hammond/",
"name": "Ed Hammond"
},
{
"webUrl": "/author/profile/scott-deveau/",
"name": "Scott Deveau"
}
],
"kickerNode": [
{
"uri": "/news/",
"sectionName": "News"
}
],
"summary": "The company has been formally exploring a sale since June, when CEO Jonathan Bush stepped down following allegations of misconduct.",
"body": null
},
{
"uri": "/2018/03/30/walmart-in-talks-to-buy-humana/",
"title": "Walmart in early talks to buy Humana",
"byline": "Zachary Tracer and Ed Hammond",
"kicker": "News",
"prettyDate": "March 30, 2018",
"timeToRead": "3 minute",
"image": {
"uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2018/03/Walmart.jpg",
"width": "600",
"height": "337"
},
"authors": [
{
"webUrl": "/author/profile/zachary-tracer/",
"name": "Zachary Tracer"
},
{
"webUrl": "/author/profile/ed-hammond/",
"name": "Ed Hammond"
}
],
"kickerNode": [
{
"uri": "/news/",
"sectionName": "News"
}
],
"summary": "Walmart and Humana have explored a wide range of options including a merger, though an outright combination isn't likely at this point, according to one source.",
"body": null
},
{
"uri": "/2016/07/07/aetna-said-to-meet-with-doj-about-humana-deal/",
"title": "Aetna said to meet with DOJ about Humana deal",
"byline": "Zachary Tracer and David McLaughlin, Ed Hammond",
"kicker": "",
"prettyDate": "July 07, 2016",
"timeToRead": "5 minute",
"image": {
"uri": "",
"width": "",
"height": ""
},
"authors": [
{
"webUrl": "/author/profile/zachary-tracer/",
"name": "Zachary Tracer"
},
{
"webUrl": "/author/profile/david-mclaughlin-ed-hammond/",
"name": "David McLaughlin, Ed Hammond"
}
],
"kickerNode": [],
"summary": "Aetna is preparing to meet with top U.S. Justice Department officials on Friday as it seeks to win antitrust approval for its Humana deal.",
"body": null
},
{
"uri": "/2015/11/19/pfizer-said-near-allergan-deal-as-treasury-eyes-ta/",
"title": "Pfizer said near Allergan deal as Treasury eyes tax inversions",
"byline": " Cynthia Koons, Ed Hammond, Ruth David, Bloomberg ",
"kicker": "",
"prettyDate": "November 19, 2015",
"timeToRead": "6 minute",
"image": {
"uri": "",
"width": "",
"height": ""
},
"authors": [
{
"webUrl": "/author/profile/cynthia-koons-ed-hammond-ruth-david-bloomberg/",
"name": "Cynthia Koons, Ed Hammond, Ruth David, Bloomberg"
}
],
"kickerNode": [],
"summary": "Buying Allergan, which is in Dublin, could let Pfizer relocate outside the U.S. for tax purposes, a transaction known as an inversion--and of course, Allergan has Botox and the Alzheimers drug Namenda.",
"body": null
},
{
"uri": "/2015/07/23/anthem-nearing-deal-to-buy-cigna-for-48-billion/",
"title": "Anthem nearing deal to buy Cigna for $48 billion",
"byline": "Ed Hammond, Jeffery McCracken, Zachary Tracer",
"kicker": "",
"prettyDate": "July 23, 2015",
"timeToRead": "3 minute",
"image": {
"uri": "",
"width": "",
"height": ""
},
"authors": [
{
"webUrl": "/author/profile/ed-hammond-jeffery-mccracken-zachary-tracer/",
"name": "Ed Hammond, Jeffery McCracken, Zachary Tracer"
}
],
"kickerNode": [],
"summary": "Anthem is nearing an agreement to buy Cigna, sources report.",
"body": null
},
{
"uri": "/2015/07/03/aetna-agrees-to-buy-humana-for-37-billion-412-16468/",
"title": "Aetna agrees to buy Humana for $37 billion",
"byline": "Phil Serafino, Ed Hammond",
"kicker": "",
"prettyDate": "July 03, 2015",
"timeToRead": "3 minute",
"image": {
"uri": "",
"width": "",
"height": ""
},
"authors": [
{
"webUrl": "/author/profile/phil-serafino-ed-hammond/",
"name": "Phil Serafino, Ed Hammond"
}
],
"kickerNode": [],
"summary": "The transaction values Humana at $230 a share based on yesterdays closing price for Aetna, the companies said in a statement Friday.",
"body": null
},
{
"uri": "/2015/06/25/aetna-said-to-be-closing-in-on-acquisition-of-huma/",
"title": "Aetna said to be closing in on acquisition of Humana",
"byline": " Matthew Campbell, Zachary Tracer and Ed Hammond ",
"kicker": "",
"prettyDate": "June 25, 2015",
"timeToRead": "3 minute",
"image": {
"uri": "",
"width": "",
"height": ""
},
"authors": [
{
"webUrl": "/author/profile/matthew-campbell-zachary-tracer/",
"name": "Matthew Campbell, Zachary Tracer"
},
{
"webUrl": "/author/profile/ed-hammond/",
"name": "Ed Hammond"
}
],
"kickerNode": [],
"summary": "The second largest U.S. health insurer Aetna appears closer to acquiring Humana and a deal could occur as early as this weekend.",
"body": null
},
{
"uri": "/2014/12/16/cvs-sets-10-billion-share-buyback/",
"title": "CVS sets $10 billion share buyback",
"byline": "Ed Hammond",
"kicker": "",
"prettyDate": "December 16, 2014",
"timeToRead": "1 minute",
"image": {
"uri": "",
"width": "",
"height": ""
},
"authors": [
{
"webUrl": "/author/profile/ed-hammond/",
"name": "Ed Hammond"
}
],
"kickerNode": [],
"summary": "The share buyback will occur over a multi-year period, the Woonsocket, Rhode Island-based company said in a statement today before a briefing for analysts and investors.",
"body": null
}
]
}
}
